Galvanize Therapeutics, Inc.

Form D Filings

Location
Redwood City, CA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001659073
Previous Names
Galvanize Therapeutics, Inc., Gala Therapeutics, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
9/10/2025 Equity $96,130,465 $96,130,465 $141,066,486 $44,936,021 7/7/2025 9/10/2025 D 000165907325000001
3/22/2022 Debt $4,000,000 $4,000,000 $4,000,000 $0 3/9/2022 3/22/2022 D 000165907322000003
3/9/2022 Debt $2,000,000 $2,000,000 $2,000,000 $0 2/23/2022 3/9/2022 D 000165907322000002
11/18/2019 Equity $15,000,000 $42,514,946 $43,000,000 $485,054 10/8/2015 11/18/2019 D/A 000165907319000005
3/13/2019 Equity $27,514,946 $27,514,946 $28,000,000 $485,054 10/8/2015 3/11/2019 D 000165907319000003